Table 3 Characteristics of women using valproate during pregnancy
Women who used valproate during pregnancy N = 335 | |
|---|---|
Ethnicity | |
White | 230 (68.7) |
Asian | 20 (6.0) |
Black | 6 (1.8) |
Mixed | 6 (1.8) |
Other | 1 (0.3) |
Missing | 72 (21.5) |
IMD | |
1 (most deprived) | 91 (28.4) |
2 | 55 (17.2) |
3 | 59 (18.4) |
4 | 72 (22.5) |
5 (least deprived) | 43 (13.4) |
Urban–rural | |
Urban | 267 (79.7) |
Rural | 53 (15.8) |
Missing | 15 (4.5) |
Smoking | |
Non-smoker | 95 (28.4) |
Current smoker | 129 (38.5) |
Former smoker | 62 (18.5) |
Missing | 49 (14.6) |
Epilepsy | 242 (72.2) |
Bipolar Disorder | 47 (14.0) |
Migraine | 13 (3.9) |
Valproate prescription within six months prior to pregnancy | 247 (73.7) |
Folic acid within six months prior to pregnancy | 207 (61.8) |
Folic acid during pregnancy | 199 (59.4) |
Pregnancy not to term | 50 (14.9) |